New research employing advanced imaging techniques finds that changes in both outer and inner bone structures contribute to higher fracture risks in older adults with type 2 diabetes, challenging reliance on bone density alone for risk assessment. A new study…
Steve Harr outlines four critical questions for Sana Biotechnology’s gene-modified islet cell therapy to revolutionise type 1 diabetes treatment, highlighting challenges in efficacy, manufacturing scale, safety, and economics. Steve Harr has set out four questions he believes will determine whether…
FibroBiologics has obtained a US patent aimed at improving pancreatic islet transplantation, marking a significant scientific milestone in its developing cell-based therapies for Type 1 diabetes amid broader research in regenerative medicine. FibroBiologics has taken another step in building out…
New research indicates that restoring body mass index to a healthy range in individuals with early-stage type 1 diabetes could significantly lower their risk of developing full-blown clinical disease, highlighting the importance of weight management in early intervention strategies. New…
Research from TrialNet indicates that restoring BMI to a healthy range in overweight or obese children and adolescents with early-stage type 1 diabetes could reduce their likelihood of disease progression, highlighting weight management as a modifiable factor in disease risk.…
Abbott has launched Libre Assist, an AI-enabled feature in its diabetes app that predicts how meals may affect blood sugar levels, aiming to shift glucose management from retrospective to real-time decision-making, unveiled at CES in Las Vegas. Abbott has unveiled…
FibroBiologics has been granted a US patent for a novel method leveraging fibroblasts to improve the survival and function of transplanted pancreatic islets, boosting prospects for advanced type 1 diabetes therapies and beyond. FibroBiologics said it has been granted a…
Novo Nordisk has begun distributing Awiqli across the United States, offering adults with type 2 diabetes a groundbreaking once-weekly basal insulin designed to simplify treatment and improve compliance, following regulatory approval and a nationwide rollout. Novo Nordisk has begun rolling…
Dr Kevin Fernando, a GP at NHS Lothian, has secured a coveted place at The Diabetes Exchange South Korea 2026, aiming to bring innovative diabetes care insights to the UK after engaging with South Korean clinicians and technology experts. Spirit…
UC Davis Health’s innovative, coordinated approach enhances blood glucose control across hospital units without increasing hypoglycaemia risk, setting a new standard in inpatient diabetes management. UC Davis Health has reported durable gains in hospital diabetes care after building a multidisciplinary…
